Redcare Pharmacy reports 18% revenue growth in Q3

Redcare Pharmacy, the SDAX-listed online pharmacy group, reported a significant increase in its third-quarter financial results, driven largely by the rise of electronic prescriptions in Germany. The company's revenue rose by 18% year-on-year to 847 million euros.

Adjusted EBITDA saw a substantial increase of 68%, reaching 28.7 million euros, performing slightly better than market expectations. This growth reflects the increasing integration of digital prescription data into online pharmacy workflows, which enhances demand and streamlines ordering processes. Following strong performance, the company had previously raised its full-year guidance in September.